Critical Care Workers Have Lower Seroprevalence of SARS-CoV-2 IgG Compared with Non-patient Facing Staff in First Wave of COVID19

1Zhu N, Zhang D, Wang W et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33.Zhu N Zhang D Wang W et al A Novel Coronavirus from Patients with Pneumonia in China, 2019 N Engl J Med 2020382 8 727 3310.1056/NEJMoa2001017709280331978945Search in Google Scholar

2WHO. Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update (available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports)WHO. Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update available from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reportsSearch in Google Scholar

3Zheng S, Fan J, Yu F et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020;369:m1443.Zheng S Fan J Yu F et al Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study BMJ 2020369m144310.1136/bmj.m1443719007732317267Search in Google Scholar

4Shah ASV, Wood R, Gribben C et al. Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study. BMJ. 2020 Oct 28;371.Shah ASV Wood R Gribben C et al Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study BMJ 2020 Oct 2837110.1136/bmj.m3582759182833115726Search in Google Scholar

5Milner A, Baker E, Jeraj S et al. Race-ethnic and gender differences in representation within the English National Health Service: a quantitative analysis. BMJ Open. 2020;10(2):e034258.Milner A Baker E Jeraj S et al Race-ethnic and gender differences in representation within the English National Health Service: a quantitative analysis BMJ Open 202010 2 e03425810.1136/bmjopen-2019-034258704482232060158Search in Google Scholar

6Williamson EJ, Walker AJ, Bhaskaran K et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430-6.Williamson EJ Walker AJ Bhaskaran K et al Factors associated with COVID-19-related death using OpenSAFELY Nature 2020584 7821 430 610.1038/s41586-020-2521-4761107432640463Search in Google Scholar

7Abbas A, Memon SF, Khatab N et al. COVID-19 risk assessments: shortcomings in the protection of Black, Asian and Minority Ethnic healthcare workers. J Hosp Infect. 2020;106(2):385-6.Abbas A Memon SF Khatab N et al COVID-19 risk assessments: shortcomings in the protection of Black, Asian and Minority Ethnic healthcare workers J Hosp Infect 2020106 2 385 610.1016/j.jhin.2020.07.012736278032681857Search in Google Scholar

8WHO. Clinical management of COVID-19. Interim Guidance 2020. (available at: htps://www.who.int/publications/i/item/clinical-management-of-covid-19).WHO. Clinical management of COVID-19 Interim Guidance 2020 available at htps://www.who.int/publications/i/item/clinical-management-of-covid-19Search in Google Scholar

9Pedregosa F, Varoquaux G, Gramfort A, et al. Journal of Machine Learning Research (2011) 12. 2825-2830.Pedregosa F Varoquaux G Gramfort A et al Journal of Machine Learning Research 2011 12 2825 2830Search in Google Scholar

10R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. R Core Team (2018). (Available online at htps://www.R-project.org/)R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria R Core Team 2018 Available online at htps://www.R-project.org/Search in Google Scholar

11Venables WN and Ripley. B.D. Modern Applied Statistics with S. Springer-Verlag. New York 2002.Venables WN and Ripley B.D. Modern Applied Statistics with S Springer-Verlag New York 200210.1007/978-0-387-21706-2Search in Google Scholar

12Fox J, Weisberg S. An R Companion to Applied Regression.3 ed. .: Sage, Thousand Oaks CA. 2019Fox J Weisberg S An R Companion to Applied Regression.3 ed Sage, Thousand Oaks CA 2019Search in Google Scholar

13Fox J, Hong J. Effect Displays in R for Multinomial and Proportional-Odds Logit Models: Extensions to the effects Package. Journal of Statistical Software, 32(1), 1-242009.Fox J Hong J Effect Displays in R for Multinomial and Proportional-Odds Logit Models: Extensions to the effects Package Journal of Statistical Software 32 1 1 24200910.18637/jss.v032.i01Search in Google Scholar

14Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological). 1995;57(1):289-300.Benjamini Y Hochberg Y Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing Journal of the Royal Statistical Society Series B (Methodological) 199557 1 289 30010.1111/j.2517-6161.1995.tb02031.xSearch in Google Scholar

15Shields A, Faustini SE, Perez-Toledo M et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020. Dec;75(12):1089-1094.Shields A Faustini SE Perez-Toledo M et al SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study Thorax 2020 Dec; 75 12 1089 109410.1136/thoraxjnl-2020-215414746204532917840Search in Google Scholar

16England PH. Weekly Coronavirus Disease 2019 (COVID-19) Surveillance Report. Summary of COVID-19 surveillance systems 2020. htps://www.gov.uk/government/news/weekly-covid-19-surveillance-report-publishedEngland PH Weekly Coronavirus Disease 2019 (COVID-19) Surveillance Report Summary of COVID-19 surveillance systems 2020 htps://www.gov.uk/government/news/weekly-covid-19-surveillance-report-publishedSearch in Google Scholar

17Struyf T, Deeks JJ, Dinnes J et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev. 2020;7:CD013665.Struyf T Deeks JJ Dinnes J et al Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease Cochrane Database Syst Rev 20207CD01366510.1002/14651858.CD013665Search in Google Scholar

18Hashmi HAS, Asif HM. Early Detection and Assessment of Covid-19. Frontiers in Medicine. 2020;7(311).Hashmi HAS Asif HM Early Detection and Assessment of Covid-19 Frontiers in Medicine 20207 31110.3389/fmed.2020.00311Search in Google Scholar

19Gómez-Ochoa SA, Franco OH, Rojas LZ et al. COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes. Am J Epidemiol. 2021 Jan 4;190(1):161-175.Gómez-Ochoa SA Franco OH Rojas LZ et al COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes Am J Epidemiol 2021 Jan 4190 1 161 17510.1093/aje/kwaa191Search in Google Scholar

20Get a free NHS test to check if you have coronavirus. 2020. (Available online at: htps://www.gov.uk/get-coronavirus-test).Get a free NHS test to check if you have coronavirus 2020 (Available online at htps://www.gov.uk/get-coronavirus-testSearch in Google Scholar

21Pollán M, Pérez-Gómez B, Pastor-Barriuso et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020 Aug 22;396(10250):535-544.Pollán M Pérez-Gómez B Pastor-Barriuso et al Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Lancet 2020 Aug 22396 10250 535 54410.1016/S0140-6736(20)31483-5Search in Google Scholar

22Surkova E, Nikolayevskyy V, Drobniewski F. False-positive COVID-19 results: hidden problems and costs. Lancet Respir Med. 2020 Dec;8(12):1167-1168.Surkova E Nikolayevskyy V Drobniewski F False-positive COVID-19 results: hidden problems and costs Lancet Respir Med 2020 Dec8 12 1167 116810.1016/S2213-2600(20)30453-7Search in Google Scholar

23Seow J, Graham C, Merrick B et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020 Dec;5(12):1598-1607.Seow J Graham C Merrick B et al Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans Nat Microbiol 2020 Dec5 12 1598 160710.1038/s41564-020-00813-8761083333106674Search in Google Scholar

24Takahashi T, Ellingson MK, Wong P et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020 Dec;588(7837):315-320.Takahashi T Ellingson MK Wong P et al Sex differences in immune responses that underlie COVID-19 disease outcomes Nature 2020 Dec588 7837 315 32010.1038/s41586-020-2700-3772593132846427Search in Google Scholar

25Mertz D, Kim TH, Johnstone Jet al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013 Aug 23;347.Mertz D Kim TH Johnstone J et al Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis BMJ 2013 Aug 2334710.1136/bmj.f5061380549223974637Search in Google Scholar

26Ishiguro T, Takayanagi N, Yamaguchi S, et al. Etiology and Factors Contributing to the Severity and Mortality of Community-acquired Pneumonia. Internal Medicine. 2013;52(3):317-24.Ishiguro T Takayanagi N Yamaguchi S et al Etiology and Factors Contributing to the Severity and Mortality of Community-acquired Pneumonia Internal Medicine 201352 3 317 2410.2169/internalmedicine.52.883023370738Search in Google Scholar

27Vermillion MS, Ursin RL, Kuok DIT et al. Production of amphiregulin and recovery from influenza is greater in males than females. Biology of Sex Differences. 2018;9(1).Vermillion MS Ursin RL Kuok DIT et al Production of amphiregulin and recovery from influenza is greater in males than females Biology of Sex Differences 20189 110.1186/s13293-018-0184-8604877130012205Search in Google Scholar

28Sekine T, Perez-Potti A, Rivera-Ballesteros O et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell. 2020 Oct 1;183(1):158-168Sekine T Perez-Potti A Rivera-Ballesteros O et al Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 Cell 2020 Oct 1183 1 158 16810.1016/j.cell.2020.08.017Search in Google Scholar

29Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13.Chen N Zhou M Dong X et al Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study The Lancet 2020395 10223 507 1310.1016/S0140-6736(20)30211-7Search in Google Scholar

30Knight SR, Ho A, Pius R et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020 Sep 9; 370.Knight SR Ho A Pius R et al Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score BMJ 2020 Sep 9 37010.1136/bmj.m3339711647232907855Search in Google Scholar

31Drefahl S, Wallace M, Mussino E et al. A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden. Nature Communications. 2020;   Oct 9;11(1):5097.Drefahl S Wallace M Mussino E et al A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden Nature Communications 2020   Oct 911 1 509710.1038/s41467-020-18926-3754767233037218Search in Google Scholar

32SIREN (Sarscov2 Immunity & REinfection EvaluatioN): The impact of detectable anti SARS-COV2 antibody on the incidence of COVID-19 in healthcare workers. 2020. (https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/siren-sars-cov2-immunity-and-reinfection-evaluation-covid-19-uph/) )SIREN (Sarscov2 Immunity & REinfection EvaluatioN): The impact of detectable anti SARS-COV2 antibody on the incidence of COVID-19 in healthcare workers 2020 https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/siren-sars-cov2-immunity-and-reinfection-evaluation-covid-19-uph/)Search in Google Scholar

1Xiong X, Qu K, Ciazynska KA, et al. A thermostable, closed SARS-CoV-2 spike protein trimer. Nat Struct Mol Biol. Oct 2020; 27(10):934-941.Xiong X Qu K Ciazynska KA et al A thermostable, closed SARS-CoV-2 spike protein trimer Nat Struct Mol Biol Oct 2020 27(10) 934-94110.1038/s41594-020-0478-5711638832737467Search in Google Scholar

2Stadlbauer D, Amanat F, Chromikova V, et al. SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup. Curr Protoc Microbiol. 06 2020;57(1)Stadlbauer D Amanat F Chromikova V et al SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay Antigen Production, and Test Setup. Curr Protoc Microbiol 06 202057(1)10.1002/cpmc.100723550432302069Search in Google Scholar

3Pedregosa F, Varoquaux G, Gramfort A, et al. Journal of Machine Learning Research (2011) 12. 2825-2830.Pedregosa F Varoquaux G Gramfort A et al Journal of Machine Learning Research (2011) 12 2825-2830Search in Google Scholar